BRPI0411772A - uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras - Google Patents

uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras

Info

Publication number
BRPI0411772A
BRPI0411772A BRPI0411772-7A BRPI0411772A BRPI0411772A BR PI0411772 A BRPI0411772 A BR PI0411772A BR PI0411772 A BRPI0411772 A BR PI0411772A BR PI0411772 A BRPI0411772 A BR PI0411772A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical compositions
heptane
neuroprotective
bicyclic derivatives
Prior art date
Application number
BRPI0411772-7A
Other languages
English (en)
Inventor
Istvan Gacsalyi
Gabor Gigler
Laszlo Gabor Harsing
Gy Rgy Levay
Krisztina Moricz
Annamaria Simo
Gabor Szenasi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of BRPI0411772A publication Critical patent/BRPI0411772A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

"USO DE DERIVADOS DE BICICLO¢2.2.1!HEPTANO PARA O PREPARO DE COMPOSIçõES FARMACêUTICAS NEUROPROTETORAS". A invenção se refere ao uso de compostos da Fórmula geral (I), em que R¬ 3¬ significa hidrogênio ou hidróxi; R¬ 1¬ significa hidrogênio ou alquila; e R¬ 2¬ significa alquila e sais de adição de ácido farmaceuticamente aceitáveis dos mesmos para o preparo de composições farmacêuticas tendo efeito neuroprotetor.
BRPI0411772-7A 2003-06-23 2004-06-22 uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras BRPI0411772A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301906A HUP0301906A3 (en) 2003-06-23 2003-06-23 Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
PCT/HU2004/000062 WO2004112769A1 (en) 2003-06-23 2004-06-22 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0411772A true BRPI0411772A (pt) 2006-08-08

Family

ID=90001689

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411772-7A BRPI0411772A (pt) 2003-06-23 2004-06-22 uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras

Country Status (23)

Country Link
US (1) US20060258750A1 (pt)
EP (1) EP1660063A1 (pt)
JP (1) JP2007516165A (pt)
KR (1) KR20060023997A (pt)
CN (1) CN1812778A (pt)
AU (1) AU2004248982A1 (pt)
BG (1) BG109414A (pt)
BR (1) BRPI0411772A (pt)
CA (1) CA2529254A1 (pt)
CZ (1) CZ200631A3 (pt)
EA (1) EA010868B1 (pt)
HR (1) HRP20060023A2 (pt)
HU (1) HUP0301906A3 (pt)
IL (1) IL172408A0 (pt)
IS (1) IS8239A (pt)
MX (1) MXPA05014127A (pt)
NO (1) NO20060277L (pt)
PL (1) PL378630A1 (pt)
RS (1) RS20050954A (pt)
SK (1) SK50082006A3 (pt)
UA (1) UA81052C2 (pt)
WO (1) WO2004112769A1 (pt)
ZA (1) ZA200510138B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
CZ2008602A3 (cs) * 2008-10-09 2009-11-25 Ústav chemických procesu Akademie ved Ceské republiky Zpusob a zarízení pro izolaci kyseliny tereftalové
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
US20060258750A1 (en) 2006-11-16
IL172408A0 (en) 2006-04-10
NO20060277L (no) 2006-01-19
EP1660063A1 (en) 2006-05-31
MXPA05014127A (es) 2006-02-24
KR20060023997A (ko) 2006-03-15
PL378630A1 (pl) 2006-05-15
AU2004248982A1 (en) 2004-12-29
HUP0301906A3 (en) 2006-03-28
BG109414A (bg) 2006-11-30
CA2529254A1 (en) 2004-12-29
HUP0301906D0 (en) 2003-08-28
RS20050954A (en) 2007-08-03
JP2007516165A (ja) 2007-06-21
HUP0301906A2 (en) 2006-02-28
CN1812778A (zh) 2006-08-02
SK50082006A3 (sk) 2006-05-04
WO2004112769A1 (en) 2004-12-29
UA81052C2 (en) 2007-11-26
IS8239A (is) 2006-01-18
ZA200510138B (en) 2007-03-28
CZ200631A3 (cs) 2006-05-17
HRP20060023A2 (en) 2006-05-31
EA200600022A1 (ru) 2006-08-25
EA010868B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
BRPI0513672A (pt) processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
BR0210028A (pt) Agentes antibacterianos
BR0112224A (pt) Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
BR0102083A (pt) Uso de derivados de alfa-cetoenamina como ingredientes
BR0014060A (pt) Derivado de quinolil propil piperidina, processo para preparação do mesmo, e, composição farmacêutica
MXPA03005464A (es) Agentes antivirales.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BRPI0511532A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia de distúrbios gastrointestinais funcionais e de sìndrome do intestino irritável em um animal de sangue quente, e para a preparação de um composto
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
MA31593B1 (fr) Derives de 2-aza-bicyclo[3.3.0]octane
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BR0111377A (pt) Derivados de tiofeno úteis como agentes anticancerìgenos
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
BR0010938A (pt) Derivados da 13-metil eritromicina
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
BR0212069A (pt) Agentes antidiabéticos orais
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
BR9905089A (pt) Derivados macrolìdeos
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
BRPI0411772A (pt) uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras
DE60114640D1 (en) Antithrombosemittel
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2082 DE 30/11/2010.